PRESS RELEASE ABBOTT PARK, Ill., April 14, today 2015 /PRNewswire/ –, Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation testing measure a person's blood clotting ability, that may help doctors assess risks of excessive bleeding or developing clots Flagyl Online . Beneath the agreement, Abbott will be the distinctive distributor of Sekisui's new CP3000 coagulation device in the United States, European countries and other regions that acknowledge CE Mark. ‘Abbott is committed to providing testing solutions that healthcare providers rely on for actionable details in diagnosing and treating various medical conditions,’ said Jaime Contreras, senior vice president, Commercial Procedures, Diagnostics, Abbott.

What does it appear to be to really live a full life – one that enriches and satisfies, that delivers happiness and enables accomplishment? Abbott is speaking with one million people worldwide to find out. And the answers aren’t as simple as you’ll think. What about a factory worker in Detroit or a new mother in Berlin? In the current hyperconnected world that is pulling us collectively in so many methods, just how do our cultural differences, lifestyle personalities and experiences impact what it means to live a full life? Early in this quest we’re seeing preliminary trends, like the role wellness plays in a full life in Shanghai and the importance of family in New York.